Cepheid’s Diagnostics First: Providing education and solutions in the AMR space

Diagnostics companies are joining the fight against antimicrobial resistance in full force as the concern for repercussions of inaction grow. One such company, Cepheid, has taken its solution provider identification even more seriously than most, launching the Diagnostics First initiative. This program champions rapid diagnostics and molecular testing as a key tool in preventing resistance. Accurate and timely diagnostic testing …

[WHITEPAPER] Rapid Molecular Diagnostics: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance

Rapid Molecular Diagnostics: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance Download the whitepaper, courtesy of Cepheid here>> Some of the most widely used therapies in medicine, antibiotics have also steadily become some of the most improperly used treatments. Antibiotics have saved many lives and changed the face of medicine, but reliance upon them has also led to serious …